Related Experiment Video
Updated: Dec 12, 2025
06:39
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
3.4K
Non-pharmacological interventions for postpartum depression: A protocol for systematic review and network
Yang Wang1,2, Hui Li3, Wei Peng4
1School of Rehabilitation and Health Preservation, Chengdu University of Traditional Chinese Medicine.
Medicine
|August 7, 2020
Summary
This network meta-analysis ranks non-pharmacological treatments for postpartum depression (PPD). It provides evidence-based guidance for selecting effective therapies for women experiencing PPD.
Area of Science:
- Reproductive Health
- Mental Health
- Evidence-Based Medicine
Background:
- Postpartum depression (PPD) is a common mental health disorder affecting women after childbirth.
- Non-pharmacological interventions are often preferred due to concerns about medication side effects.
- High-quality evidence is needed to guide the selection of effective non-drug therapies for PPD.
Purpose of the Study:
- To compare and rank various non-pharmacological interventions for postpartum depression.
- To interpret existing evidence on the effectiveness of these treatments.
- To provide evidence-based recommendations for clinicians and patients.
Main Methods:
- A systematic search of multiple electronic bibliographic databases for relevant randomized controlled trials (RCTs).
- Analysis of heterogeneity and inconsistencies using I statistic and Z test.
- Assessment of evidence quality using GRADE and risk of bias using Cochrane risk of bias tool.
- Network meta-analysis conducted using R software.
Main Results:
- The study will establish a hierarchy of effectiveness for different non-pharmacological PPD treatments.
- Findings will be reported in a recognized scientific journal.
Conclusions:
- The review will ascertain the hierarchy of effectiveness for non-pharmacological PPD treatments.
- Systematic recommendations will be provided for physicians and patients to guide treatment choices.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
666
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
666
01:18Depression: Overview
634
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
634
01:27Depressive Disorders: Etiology
331
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
331